Ototoxicity (cochleotoxicity) classifications: A review

References

• Arora R., Thakur J., Azad R. et al. 2009. Cisplatin based chemotherapy: Add high-frequency audiometry in the regimen. Indian J Cancer, 46 (4), 311–314.
   PubMedGoogle Scholar
• American Speech Language Hearing Association. 1994. Audiologic management of individuals receiving cochleotoxic drug therapy; guidelines. Available from www.asha.org/policy.
   Google Scholar
• Blakley B. & Myers S. 1993. Patterns of hearing loss resulting from cis-platinum therapy. Otolaryngol Head Neck Surg, 109(3, pt. 1), 385–391.
   PubMed Web of Science ®Google Scholar
• Brock P., Bellman S., Yeomans E. et al 1991. Cisplatin ototoxicity in children: A practical grading system. Med Pediatr Oncol, 19, 295–300.
   PubMedGoogle Scholar
• Brock P., Knight K., Freyer D. et al. 2012. Platinum induced ototoxicity in children: A consensus review on mechanisms, predisposition and protection, including a new international society of pediatric oncology Boston ototoxicity scale. J Clin Oncol, 30(19), 2408–2417.
   PubMed Web of Science ®Google Scholar
• Brummet R. & Fox K. 1989. Aminoglycoside-induced hearing loss in humans. Antimicrobial Agents and Chemotherapy, 33(6), 797–800.
   PubMed Web of Science ®Google Scholar
• Chang K. & Chinosornvatana N. 2010. Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol, 28, 1788–1795.
   PubMed Web of Science ®Google Scholar
• Cooke R. 1990. Classification of audiometric results. J Soc Occup Med, 40, 117.
   PubMedGoogle Scholar
• Dille M., Konrad Martin D., Gallun F. et al. 2010. Tinnitus onset rates for chemotherapeutic agents and ototoxic antibiotics: Results of a large prospective study. J Am Acad Audiol, 21, 409–417.
   PubMed Web of Science ®Google Scholar
• Ding D., Allman B., Yin S. et al. 2011. Cisplatin Ototoxicity. In: J. Dupont (ed.) Hearing loss: Classification Causes and Treatment, New York: Nova Science Publishers.
   Google Scholar
• Dhooge I., Dhooge C., Guekens S. et al. 2006. Distortion product otoacoustic emissions: An objective technique for the screening of hearing loss in children treated with platin derivatives. Int J Audiol, 45, 337–343.
   PubMed Web of Science ®Google Scholar
• Einarsson E., Peterson H., Wiebe T. et al. 2010. Long-term hearing degeneration after platinum based chemotherapy in childhood. Int J Audiol, 49, 765–771.
   PubMed Web of Science ®Google Scholar
• Fouladi M., Chintagumpala M., Ashley D. et al. 2008. Amifostine protects against cisplatin induced ototoxicity in children with average risk medulloblastoma. J Clin Oncol, 26(22), 3749–3755.
   PubMed Web of Science ®Google Scholar
• Grewal S., Merchant T., Reymond R. et al. 2010. Auditory late effects of childhood cancer therapy: A report from the children oncology group. Pediatrics, 125(4), 938–950.
   PubMed Web of Science ®Google Scholar
• Guida H., Morini R. & Cardoso A. 2010. Audiological evaluation in workers exposed to noise and pesticide. Braz J Otorhinolaryngol, 76 (4), 423–427.
   PubMed Web of Science ®Google Scholar
• Gurney J. & Bass J. 2012. New international society of pediatric oncology, Boston ototoxicity grading scale for pediatric oncology: Still room for improvement. J Clin Oncol, 30(19), 2303–2306.
   PubMed Web of Science ®Google Scholar
• Harris T., Peer S. & Fagan J. 2012. Audiological monitoring for ototoxic tuberculosis human immunodeficiency virus and cancer therapies in a developing world setting. J Laryngol Otol, 126, 548–551.
   PubMed Web of Science ®Google Scholar
• Huang E., Teh B., Strother D. et al. 2002. Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity. International Journal of Radiation Oncology Biology Physics, 52(3), 599–605.
   PubMed Web of Science ®Google Scholar
• Jung T., Rhee C., Lee C. et al. 1993. Ototoxicity of salicylate, nonsteroidal anti-inflammatory drugs, and quinine. Otolaryngol Clin North Am, 26(5), 791–810.
   PubMed Web of Science ®Google Scholar
• Khan A., D’Souza B., Wharam M. et al. 1982. Cis-platin therapy in recurrent childhood brain tumours. Cancer Treat Rep, 66, 2013–2020.
   PubMedGoogle Scholar
• Kim H. & Barrs D. 2006. Hearing aids: A review of what’s new. Otolaryngol Head Neck Surg, 134, 1043–1050.
   PubMed Web of Science ®Google Scholar
• Knight K., Kraemer D. & Neuwelt E. 2005. Ototoxicity in children receiving platinum chemotherapy: Underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol, 23(34), 8588–8596.
   PubMed Web of Science ®Google Scholar
• Knight K., Kraemer D. & Winter C. et al. 2007. Early changes in auditory function as a result of platinum chemotherapy: Use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions. J Clin Oncol, 25(10), 1190–1195.
   PubMed Web of Science ®Google Scholar
• Konrad-Martin D., James K., Gordon J. et al. 2010. Evaluation of audiometric threshold shift criteria for ototoxicity monitoring. J Am Acd Audiol, 21, 301–314.
   PubMed Web of Science ®Google Scholar
• Konrad-Martin D., Reavis K., McMillan G. et al. 2014 Proposed comprehensive ototoxicity monitoring program for VA health care (COMP-VA). Journal of Rehabilitation Research and Development, 51(1), 81–100.
   PubMed Web of Science ®Google Scholar
• Lewis M., Dubois S., Fligor B. et al. 2009. Ototoxicity in children treated for osteosarcoma. Pediatric Blood Cancer, 52, 387–391.
   PubMed Web of Science ®Google Scholar
• Margolis R. & Saly G. 2007. Toward a standard description of hearing loss. Int J Audiol, 46, 46–758.
   Web of Science ®Google Scholar
• Meyer T., Canty P., Wilkinson E. et al. 2006. Small acoustic neuromas: Surgical outcomes versus observation or radiation. Otol Neurotol, 27, 380–392.
   PubMed Web of Science ®Google Scholar
• Moeller B., Chintagumpala M., Philip J. et al. 2011. Low early ototoxicity rates for pediatric medulloblastoma patients treated with proton radiotherapy. Radiation Oncology, 6, 58–64.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. 2003. National Cancer Institute Common Terminology for Adverse Events version 3. Available from http://evs.nci.nih.gov/.
   Google Scholar
• National Cancer Institute. 2010. National Cancer Institute Common Terminology for Adverse Events version 4. Available from http://evs.nci.nih.gov/.
   Google Scholar
• National Cancer Institute. 2014. National Cancer Institute Cancer Therapy Evaluation Program, Protocol development. Available from http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm
   Google Scholar
• Neuwelt E. & Brock P. 2010. Critical need for international consensus on ototoxicity assessment criteria. J Clin Oncol, 28, 1630–1632.
   PubMed Web of Science ®Google Scholar
• Postma T. & Heimans J. 2000. Grading of chemotherapy induced peripheral neuropathy. Annals of Oncology, 11, 509–513.
   PubMed Web of Science ®Google Scholar
• Qaddoumi I., Bass J., Wi J. et al. 2012. Carboplatin: Associated ototoxicity in children with retinoblastoma. J Clin Oncol, 30(10), 1034–1041.
   PubMed Web of Science ®Google Scholar
• Rybak L. 1992. Hearing: The effects of chemicals. Otolaryngol Head Neck Surg, 106(6), 677–686.
   PubMed Web of Science ®Google Scholar
• Rybak L. 1993. Ototoxicity of loop diuretics. Otolaryngol Clin North Am, 26(5), 829–844.
   PubMed Web of Science ®Google Scholar
• Rybak L. & Rakumar V. 2007. Ototoxicity. International Society of Nephrology, 72, 931–935.
   Google Scholar
• Robert W., Taylor J. & White N. 2004. Antimalarial drug toxicity. Drug Safety, 27(1), 25–61.
   PubMed Web of Science ®Google Scholar
• Samelli A., Rabelo C. & Vespasiano A. 2011. Development and analysis of a low cost screening tool to identify and classify hearing loss in children: A proposal for developing countries. Clinics, 66(11), 1943–1948.
   PubMed Web of Science ®Google Scholar
• Schultz C., Gomez M. & Liberman P. et al. 2009. Report on hearing loss in oncology. Braz J Otorhinolaryngol, 75(5), 634–641.
   PubMedGoogle Scholar
• Schmidt C., Bartholomaus E., Deutser D. et al. 2007. Die Munsteraner Klassification: Eine neue einteilung der Hochton-schwerhorigkeit nach Cisplatingabe. HNO, 55, 299–306.
   PubMed Web of Science ®Google Scholar
• Stöhr W., Langer T., Kremers S. et al. 2005. Cisplatin: Induced ototoxicity in osteosarcoma patients: A report from the late effects surveillance system. Cancer Investigation, 23, 201–207.
   PubMed Web of Science ®Google Scholar
• Stuart A. Stenstrom R., Tompkins C. et al. 1991. Test-retest variability in audiometric threshold with supra-aural and insert earphones among children and adults. Audiology, 30, 82–90.
   PubMedGoogle Scholar
• Theunissen E., Dreschler W., Latenstein M. et al. 2014. A new grading system for ototoxicity in adults. Ann Otol Rhinol Laryngol, 123(10) 711–718.
   Google Scholar
• World Health Organization. 1991. Grades of hearing impairment. Hearing network. News. 1.
   Google Scholar